| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 124 | 4.664 | 4.935 | 4.488 | 5.839 | 4.343 | 6.122 | 9.392 | 6.516 | 4.223 |
| Total Income - EUR | 124 | 4.664 | 4.935 | 4.918 | 5.839 | 4.343 | 6.122 | 9.392 | 7.537 | 5.846 |
| Total Expenses - EUR | 57 | 3.779 | 4.008 | 4.253 | 4.995 | 4.015 | 4.693 | 6.550 | 7.097 | 6.427 |
| Gross Profit/Loss - EUR | 67 | 885 | 926 | 664 | 844 | 328 | 1.429 | 2.842 | 441 | -581 |
| Net Profit/Loss - EUR | 63 | 745 | 778 | 517 | 669 | 241 | 1.429 | 2.696 | 375 | -581 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tumurtax Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.791 | 1.054 | 345 | 0 | 0 | 0 | 0 |
| Current Assets | 308 | 1.050 | 1.810 | 310 | 824 | 1.739 | 3.467 | 6.187 | 4.877 | 2.055 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 223 | 191 | 187 | 192 | 192 | 233 | 227 | 210 | 254 | 44 |
| Cash | 85 | 859 | 1.623 | 117 | 632 | 1.506 | 3.239 | 5.976 | 4.623 | 2.011 |
| Shareholders Funds | -848 | -94 | 685 | 1.189 | 1.878 | 2.083 | 3.467 | 6.173 | 4.508 | 1.688 |
| Social Capital | 45 | 45 | 44 | 43 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 1.156 | 1.144 | 1.125 | 911 | 0 | 0 | 0 | 14 | 369 | 367 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Tumurtax Srl